Posted inMarket
Kofola Reports Strong First Half 2026 Performance with Higher Revenues and Margins
Discover Kofola's strong first half 2026 financial results, featuring a 10 percent revenue increase and improved EBITDA margins.
Posted inBusiness Insights
Cipla Reaffirms Full-Year Profit Guidance as $1 Billion US Revenue Target Paves Way for FY27 Growth Ramp-Up
Indian pharmaceutical major Cipla Limited announced it is maintaining its full-year EBITDA margin guidance of 18.5% to 20%, anchored by a projected U.S. sales run rate of $1 billion by…
